Literature DB >> 6335855

Microvascular abnormalities as possible predictors of disease subsets in Raynaud phenomenon and early connective tissue disease.

H R Maricq, F E Harper, M M Khan, E M Tan, E C LeRoy.   

Abstract

In vivo capillary examination was performed on 80 patients included in a prospective study of Raynaud phenomenon (RP): 40 RP only (RPO), 20 undifferentiated connective tissue disease (UCTD) and 20 systemic scleroderma (SD) of less than 5 years' duration. On initial examination, SD-pattern capillary abnormalities were found in 7/40 patients with RP alone, 18/20 with UCTD and 19/20 with SD. On follow-up a change of diagnosis into a definite connective tissue disease occurred in 4 patients with UCTD; one patient with RP alone died with symptoms of myositis and fulminant pulmonary vasculitis. All five showed SD-pattern capillary abnormalities of the "active" type on initial examination. A significant correlation between the "slow" capillary pattern and the presence of anticentromere antibodies was also observed. Only one patient of 25 RPO with normal capillaries available for follow-up showed any change in clinical status.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6335855

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN: 0392-856X            Impact factor:   4.473


  33 in total

1.  Vascular leak is a central feature in the pathogenesis of systemic sclerosis.

Authors:  Tracy M Frech; Monica P Revelo; Stavros G Drakos; Maureen A Murtaugh; Boaz A Markewitz; Allen D Sawitzke; Dean Y Li
Journal:  J Rheumatol       Date:  2012-06-01       Impact factor: 4.666

2.  Comparison of qualitative and quantitative analysis of capillaroscopic findings in patients with rheumatic diseases.

Authors:  Sevdalina Nikolova Lambova; Walter Hermann; Ulf Müller-Ladner
Journal:  Rheumatol Int       Date:  2011-12-07       Impact factor: 2.631

3.  Capillaroscopy: questions and answers.

Authors:  Walter Grassi; Rossella De Angelis
Journal:  Clin Rheumatol       Date:  2007-07-14       Impact factor: 2.980

Review 4.  Raynaud's phenomenon: its relevance to scleroderma.

Authors:  J J Belch
Journal:  Ann Rheum Dis       Date:  1991-11       Impact factor: 19.103

Review 5.  [Therapeutic management in early disease stages of systemic sclerosis : early diagnosis - early symptoms - early problems].

Authors:  M Frerix; F M P Meier; W Hermann; U Müller-Ladner
Journal:  Z Rheumatol       Date:  2013-12       Impact factor: 1.372

Review 6.  Autoantibodies to components of the mitotic apparatus.

Authors:  J B Rattner; G J Mack; M J Fritzler
Journal:  Mol Biol Rep       Date:  1998-07       Impact factor: 2.316

Review 7.  Clinical relevance of autoantibodies in systemic rheumatic diseases.

Authors:  M J Fritzler
Journal:  Mol Biol Rep       Date:  1996       Impact factor: 2.316

Review 8.  Moving towards a molecular taxonomy of autoimmune rheumatic diseases.

Authors:  Guillermo Barturen; Lorenzo Beretta; Ricard Cervera; Ronald Van Vollenhoven; Marta E Alarcón-Riquelme
Journal:  Nat Rev Rheumatol       Date:  2018-01-24       Impact factor: 20.543

9.  Items for developing revised classification criteria in systemic sclerosis: Results of a consensus exercise.

Authors:  Jaap Fransen; Sindhu R Johnson; Frank van den Hoogen; Murray Baron; Yannick Allanore; Patricia E Carreira; László Czirják; Christopher P Denton; Oliver Distler; Daniel E Furst; Armando Gabrielli; Ariane Herrick; Murat Inanc; Bashar Kahaleh; Otylia Kowal-Bielecka; Thomas A Medsger; Ulf Mueller-Ladner; Gabriela Riemekasten; Stanislaw Sierakowski; Gabriele Valentini; Doug Veale; Madelon C Vonk; Ulrich Walker; Lorinda Chung; Philip J Clements; David H Collier; Mary E Csuka; Sergio Jimenez; Peter A Merkel; James R Seibold; Richard Silver; Virginia Steen; Alan Tyndall; Marco Matucci-Cerinic; Janet E Pope; Dinesh Khanna
Journal:  Arthritis Care Res (Hoboken)       Date:  2012-03       Impact factor: 4.794

10.  Raynaud's phenomenon in undifferentiated connective tissue disease (UCTD).

Authors:  Rossella De Angelis; Angela Cerioni; Patrizia Del Medico; Patrizia Blasetti
Journal:  Clin Rheumatol       Date:  2004-09-04       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.